Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04792931
  4. Details
NCT04792931 Clinical Trial

Adult Autoimmune Myopathies (MAIA)

Idiopathic Inflammatory Myopathies Clinical Trial

— MAIA  

Official title:
Adult Autoimmune Myopathies (MAIA): Clinical and Immunological Characterization, Constitution of a Patient Library

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04792931
Other study ID # 29BRC20.0276
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 20, 2022
Est. completion date May 20, 2030

Study information
Verified date May 2022
Source University Hospital, Brest
Contact Dewi GUELLEC
Phone 0230337617
Email dewi.guellec@chu-brest.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study corresponds to a monocentric prospective cohort of adult patients presenting a suspicion of idiopathic inflammatory myopathy. It will allows the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood sample, urine, stool and muscle specimen.

Recruitment information / eligibility
Status Recruiting
Enrollment 60
Est. completion date May 20, 2030
Est. primary completion date May 20, 2030
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinical suspicion of Adult Inflammatory Myopathy - Social security affiliation Exclusion Criteria: - Pregnant and lactating women - Patients unable to consent - Patients refusing to participate in the research. - Patients under legal protection

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• description of adult autoimmune myopathies
description of adult autoimmune myopathies

Locations
Country Name City State
France CHU de BREST Brest

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Distribution of lymphocytes subpopulations (B, T and TH-17) Distribution of lymphocytes subpopulations (B, T and TH-17) according to the final diagnosis defined by a panel of experts 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05833711 - Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy Phase 2
Recruiting NCT04561557 - Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System Early Phase 1
Completed NCT04208464 - JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM Phase 2
Completed NCT03267277 - Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis Phase 2/Phase 3
Recruiting NCT06316076 - Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases Phase 1
Not yet recruiting NCT06350110 - Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) Phase 1/Phase 2
Recruiting NCT05879419 - Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Phase 4
Not yet recruiting NCT06417398 - Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases Early Phase 1
Not yet recruiting NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Phase 2
Recruiting NCT04664465 - PRediction Of DIverse Glucocorticoids toxIcity OUtcomeS
Not yet recruiting NCT06152172 - CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101 Phase 1
Recruiting NCT05400889 - Clinical Characteristics and Mechanism Research of Inhibitors of Janus Kinase in the Idiopathic Inflammatory Myopathies Phase 2
Completed NCT03918356 - Application of Electrical Impedance Myography (EIM) as a Potential Biomarker of Idiopathic Inflammatory Myopathies N/A
Completed NCT00341679 - Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
Recruiting NCT05952531 - Characterizing Myositis With 68Ga-FAPI PET/CT Early Phase 1
Recruiting NCT05200702 - Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders N/A
Completed NCT03092167 - Physical Training in Patients With Idiopathic Inflammatory Myopathies N/A
Recruiting NCT03092180 - Optimizing Treatment on Idiopathic Inflammatory Myopathies
Recruiting NCT05199246 - Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders N/A
Not yet recruiting NCT04034199 - Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid Phase 3